10-63193075-G-A

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBS1BS2

The NM_032776.3(JMJD1C):​c.5939C>T​(p.Pro1980Leu) variant causes a missense change. The variant allele was found at a frequency of 0.0344 in 1,613,898 control chromosomes in the GnomAD database, including 1,144 homozygotes. In-silico tool predicts a benign outcome for this variant. 14/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. P1980R) has been classified as Uncertain significance.

Frequency

Genomes: 𝑓 0.024 ( 65 hom., cov: 32)
Exomes 𝑓: 0.035 ( 1079 hom. )

Consequence

JMJD1C
NM_032776.3 missense

Scores

1
17

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:2

Conservation

PhyloP100: 5.13

Publications

14 publications found
Variant links:
Genes affected
JMJD1C (HGNC:12313): (jumonji domain containing 1C) The protein encoded by this gene interacts with thyroid hormone receptors and contains a jumonji domain. It is a candidate histone demethylase and is thought to be a coactivator for key transcription factors. It plays a role in the DNA-damage response pathway by demethylating the mediator of DNA damage checkpoint 1 (MDC1) protein, and is required for the survival of acute myeloid leukemia. Mutations in this gene are associated with Rett syndrome and intellectual disability. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Dec 2015]
JMJD1C Gene-Disease associations (from GenCC):
  • 22q11.2 deletion syndrome
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • complex neurodevelopmental disorder
    Inheritance: AD Classification: LIMITED Submitted by: Illumina
  • neurodevelopmental disorder
    Inheritance: AD Classification: LIMITED Submitted by: G2P

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.0031484067).
BP6
Variant 10-63193075-G-A is Benign according to our data. Variant chr10-63193075-G-A is described in ClinVar as Benign. ClinVar VariationId is 460262.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS1
Variant frequency is greater than expected in population nfe. GnomAd4 allele frequency = 0.0241 (3662/152206) while in subpopulation NFE AF = 0.0392 (2663/68012). AF 95% confidence interval is 0.0379. There are 65 homozygotes in GnomAd4. There are 1606 alleles in the male GnomAd4 subpopulation. Median coverage is 32. This position passed quality control check.
BS2
High AC in GnomAd4 at 3662 AD gene.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
JMJD1CNM_032776.3 linkc.5939C>T p.Pro1980Leu missense_variant Exon 16 of 26 ENST00000399262.7 NP_116165.1 Q15652-1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
JMJD1CENST00000399262.7 linkc.5939C>T p.Pro1980Leu missense_variant Exon 16 of 26 5 NM_032776.3 ENSP00000382204.2 Q15652-1

Frequencies

GnomAD3 genomes
AF:
0.0241
AC:
3662
AN:
152088
Hom.:
65
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.00570
Gnomad AMI
AF:
0.00658
Gnomad AMR
AF:
0.0239
Gnomad ASJ
AF:
0.0291
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.0154
Gnomad FIN
AF:
0.0143
Gnomad MID
AF:
0.0127
Gnomad NFE
AF:
0.0392
Gnomad OTH
AF:
0.0291
GnomAD2 exomes
AF:
0.0253
AC:
6305
AN:
249414
AF XY:
0.0260
show subpopulations
Gnomad AFR exome
AF:
0.00536
Gnomad AMR exome
AF:
0.0124
Gnomad ASJ exome
AF:
0.0312
Gnomad EAS exome
AF:
0.000111
Gnomad FIN exome
AF:
0.0179
Gnomad NFE exome
AF:
0.0395
Gnomad OTH exome
AF:
0.0262
GnomAD4 exome
AF:
0.0355
AC:
51858
AN:
1461692
Hom.:
1079
Cov.:
31
AF XY:
0.0350
AC XY:
25455
AN XY:
727152
show subpopulations
African (AFR)
AF:
0.00606
AC:
203
AN:
33474
American (AMR)
AF:
0.0136
AC:
607
AN:
44724
Ashkenazi Jewish (ASJ)
AF:
0.0299
AC:
782
AN:
26134
East Asian (EAS)
AF:
0.0000252
AC:
1
AN:
39692
South Asian (SAS)
AF:
0.0150
AC:
1298
AN:
86254
European-Finnish (FIN)
AF:
0.0191
AC:
1020
AN:
53380
Middle Eastern (MID)
AF:
0.0255
AC:
147
AN:
5768
European-Non Finnish (NFE)
AF:
0.0412
AC:
45825
AN:
1111876
Other (OTH)
AF:
0.0327
AC:
1975
AN:
60390
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.468
Heterozygous variant carriers
0
2625
5251
7876
10502
13127
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
1708
3416
5124
6832
8540
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0241
AC:
3662
AN:
152206
Hom.:
65
Cov.:
32
AF XY:
0.0216
AC XY:
1606
AN XY:
74410
show subpopulations
African (AFR)
AF:
0.00568
AC:
236
AN:
41516
American (AMR)
AF:
0.0239
AC:
365
AN:
15290
Ashkenazi Jewish (ASJ)
AF:
0.0291
AC:
101
AN:
3470
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5188
South Asian (SAS)
AF:
0.0154
AC:
74
AN:
4814
European-Finnish (FIN)
AF:
0.0143
AC:
151
AN:
10594
Middle Eastern (MID)
AF:
0.0170
AC:
5
AN:
294
European-Non Finnish (NFE)
AF:
0.0392
AC:
2663
AN:
68012
Other (OTH)
AF:
0.0288
AC:
61
AN:
2116
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.501
Heterozygous variant carriers
0
182
364
546
728
910
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
44
88
132
176
220
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0327
Hom.:
344
Bravo
AF:
0.0245
TwinsUK
AF:
0.0440
AC:
163
ALSPAC
AF:
0.0433
AC:
167
ESP6500AA
AF:
0.00607
AC:
23
ESP6500EA
AF:
0.0350
AC:
289
ExAC
AF:
0.0252
AC:
3040
Asia WGS
AF:
0.00375
AC:
13
AN:
3478
EpiCase
AF:
0.0382
EpiControl
AF:
0.0391

ClinVar

Significance: Benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:1
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Early myoclonic encephalopathy Benign:1
Feb 04, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.061
BayesDel_addAF
Benign
-0.58
T
BayesDel_noAF
Benign
-0.58
CADD
Benign
17
DANN
Benign
0.89
DEOGEN2
Benign
0.0088
.;T;.
Eigen
Benign
-0.087
Eigen_PC
Benign
0.034
FATHMM_MKL
Uncertain
0.96
D
LIST_S2
Benign
0.76
T;T;T
MetaRNN
Benign
0.0031
T;T;T
MetaSVM
Benign
-1.1
T
MutationAssessor
Benign
0.34
.;N;.
PhyloP100
5.1
PrimateAI
Benign
0.32
T
PROVEAN
Benign
0.24
.;N;N
REVEL
Benign
0.063
Sift
Benign
0.068
.;T;D
Sift4G
Benign
0.13
.;T;T
Polyphen
0.0
.;B;.
Vest4
0.090, 0.15
MPC
0.14
ClinPred
0.015
T
GERP RS
4.7
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.7
Varity_R
0.031
gMVP
0.15
Mutation Taster
=99/1
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs41274064; hg19: chr10-64952835; COSMIC: COSV105893319; COSMIC: COSV105893319; API